Market revenue in 2023 | USD 78.9 million |
Market revenue in 2030 | USD 119.5 million |
Growth rate | 6.1% (CAGR from 2023 to 2030) |
Largest segment | X-ray/computed tomography |
Fastest growing segment | Ultrasound |
Historical data | 2018 - 2022 |
Base year | 2023 |
Forecast period | 2024 - 2030 |
Quantitative units | Revenue in USD million |
Market segmentation | Ultrasound, Magnetic Resonance Imaging, X-ray/Computed Tomography |
Key market players worldwide | Bayer AG, GE Aerospace, Guerbet, Bracco, Lantheus Holdings Inc, Imax Corp, Nano Therapeutics, Trivitron Healthcare |
No credit card required*
Name | Profile | # Employees | HQ | Website |
---|
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to contrast media market will help companies and investors design strategic landscapes.
X-ray/computed tomography was the largest segment with a revenue share of 64.39% in 2023. Horizon Databook has segmented the Canada contrast media market based on ultrasound, magnetic resonance imaging, x-ray/computed tomography covering the revenue growth of each sub-segment from 2018 to 2030.
In Canada, the government is striving to reduce costs associated with medical imaging tests as they form a costly component of the healthcare system. This, coupled with appropriate process, has led to a downward pressure on procedure volumes, causing healthcare professionals to think twice before ordering tests as it has been observed that some of the tests are unnecessary & detrimental to the wellbeing of patients and the healthcare system.
Eight Canadian Medical Societies have prepared a list of diagnostic tests that should not be performed unless patients show symptoms that are considered a red flag. Unnecessary medical imaging tests increase the risk of cancer and nephrogenic systemic fibrosis due to radiation exposure.
A safety review was conducted by Health Canada for GBCA due to growing evidence of gadolinium deposition in the brain, following which manufacturers have added the necessary contraindications to labels.
Horizon Databook provides a detailed overview of country-level data and insights on the Canada contrast media market , including forecasts for subscribers. This country databook contains high-level insights into Canada contrast media market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account